ImageneBio IMA
NASDAQ IMA
$4.09 -0.05 (-1.09%)
At close: Oct 21, 2026 · 4:00 PM EDT

ImageneBio (IMA) Restructuring Costs (2024 - 2025)

Updated

ImageneBio's Restructuring Costs was $309,000 in Q2 2025, down 54.8% from $683,000 a year earlier and down 78.5% from the prior quarter.

Analysis

ImageneBio (IMA) Restructuring Costs (2024 - 2025) Analysis & Trends

On a trailing twelve-month basis, ImageneBio's Restructuring Costs was $2.9 million through Jun 30, 2025; for FY2024, it was $4.42 million.

  • Per Business Quant data, IMA's Restructuring Costs in the three quarters before Q2 2025 was $1.44 million (Q1 2025), $342,000 (Q4 2024) and $812,000 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 ImageneBio 34.70 Mn -452.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 309,000.00
Mar 31, 2025 1.44 Mn
Dec 31, 2024 342,000.00
Sep 30, 2024 812,000.00
Jun 30, 2024 683,000.00
Mar 31, 2024 2.60 Mn
API Access

ImageneBio Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=IMA&period=max&api_key=YOUR_API_KEY